Diane L. Tribble

9.0k citations

65 papers · 7.2k indexed · 3 hit papers · h-index 34

Surgery top 0.5%
Endocrinology, Diabetes and Metabolism top 0.5%
Nutrition and Dietetics top 0.5%
Molecular Biology top 5%
Public Health, Environmental and Occupational Health top 1%

Co-authors: Ronald M. Krauss Alan Chait Dean P. Jones Ronald Brazg Peter D. Wood Robert H. Eckel John W. Suttie Rebecca M. Mullis
Topics: Lipoproteins and Cardiovascular Health (29 papers)Antioxidant Activity and Oxidative Stress (22 papers)Cancer, Lipids, and Metabolism (14 papers)
Cited by: Biochemistry Endocrinology, Diabetes and Metabolism Nutrition and Dietetics
Journals: Proceedings of the National Academy of Sciences The Lancet Circulation
Partner nations: United States Netherlands Norway

In The Last Decade

Diane L. Tribble

63 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AHA Dietary Guidelines

2000 1.2k citations Ronald M. Krauss, Diane L. Tribble et al. Circulation profile →
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

2010 692 citations Frederick J. Raal, Raúl D. Santos et al. The Lancet profile →
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans

2002 527 citations Thomas Sudhop, Dieter Lütjohann et al. Circulation profile →

Peers

Countries citing papers authored by Diane L. Tribble

Since Specialization

Citations

This map shows the geographic impact of Diane L. Tribble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane L. Tribble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane L. Tribble more than expected).

Fields of papers citing papers by Diane L. Tribble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane L. Tribble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane L. Tribble. The network helps show where Diane L. Tribble may publish in the future.

Co-authorship network of co-authors of Diane L. Tribble

This figure shows the co-authorship network connecting the top 25 collaborators of Diane L. Tribble. A scholar is included among the top collaborators of Diane L. Tribble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane L. Tribble. Diane L. Tribble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia 2011 ·American Heart Journal ·Hayes M. Dansky,Daniel M. Bloomfield,Patrice H. Gibbons,Sherry Liu,Christine McCrary Sisk,Diane L. Tribble,James M. McKenney,Thomas Littlejohn,Yale Mitchel	24
2	Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia 2011 ·European Heart Journal ·Fatima Akdim,Diane L. Tribble,JoAnn Flaim,Rosie Z. Yu,John Q. Su,Richard S. Geary,Brenda F. Baker,Rainard Fuhr,Mark K. Wedel,John J.P. Kastelein	102
3	Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy 2010 ·Journal of the American College of Cardiology ·Fatima Akdim,Erik S.G. Stroes,Eric J.G. Sijbrands,Diane L. Tribble,Mieke D. Trip,J. Wouter Jukema,JoAnn Flaim,John Q. Su,Rosie Z. Yu,Brenda F. Baker,Mark K. Wedel,John J.P. Kastelein	128
4	Abstract 19931: Mipomersen, An Apolipoprotein B Synthesis Inhibitor, Reduces Small LDL Particle Number and Increases LDL Particle Size in Patients with Heterozygous Familial Hypercholestrolemia and Coronary Artery Disease 2010 ·Circulation ·William C. Cromwell,Robert Dufour,Claude Gagné,Daniel Gaudet,Cara East,Joanne M. Donovan,Wai Chin,Diane L. Tribble,Mary P. McGowan	2
5	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialbreakdown → 2010 ·The Lancet ·Frederick J. Raal,Raúl D. Santos,Dirk Blom,A. David Marais,Min‐Ji Charng,William C. Cromwell,Robin Lachmann,Daniel Gaudet,Ju Le Tan,Scott Chasan-Taber,Diane L. Tribble,JoAnn Flaim,Stanley T. Crooke	692
6	Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men 2009 ·Journal of Lipid Research ·Thomas Sudhop,Michaël Reber,Diane L. Tribble,Aditi Sapre,(unknown),Patrice H. Gibbons,(unknown),Klaus von Bergmann,Dieter Lütjohann	61
7	Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe 2008 ·Clinical Pharmacokinetics ·Rosie Z. Yu,Richard S. Geary,(unknown),(unknown),Diane L. Tribble,(unknown),Mark K. Wedel	82
8	Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients 2008 ·American Heart Journal ·Daniel M. Bloomfield,Gary L. Carlson,Aditi Sapre,Diane L. Tribble,James M. McKenney,Thomas Littlejohn,Christine McCrary Sisk,Yale Mitchel,Richard C. Pasternak	184
9	Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia 2008 ·Metabolism ·Diane L. Tribble,Michel Farnier,Geraldine Macdonell,Inna Perevozskaya,Michael J. Davies,Barry Gumbiner,(unknown)	31
10	Efficacy and Safety of Ezetimibe/Simvastatin Versus Simvastatin Monotherapy in Hypercholesterolemic Patients with Metabolic Syndrome 2007 ·Metabolic Syndrome and Related Disorders ·Theodore Feldman,Leiv Ose,Arvind Shah,(unknown),Alan G. Meehan,Amy O. Johnson‐Levonas,Darbie Maccubbin,Diane L. Tribble,Enrico P. Veltri,Yale Mitchel	6
11	Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis 2006 ·Current Medical Research and Opinion ·Leiv Ose,Arvind Shah,Michael J. Davies,J. Rotonda,Darbie Maccubbin,Diane L. Tribble,Enrico P. Veltri,Yale Mitchel	17
12	Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: A post Hoc analysis of subpopulations from three pooled clinical trials 2006 ·Clinical Therapeutics ·Theodore Feldman,Michael H. Davidson,Arvind Shah,Darbie Maccubbin,Alan G. Meehan,(unknown),Diane L. Tribble,Enrico P. Veltri,Yale Mitchel	17
13	1008-183 Effects of ezetimibe, simvastatin, and ezetimibe-simvastatin on noncholesterol sterol 2004 ·Journal of the American College of Cardiology ·Gerd Assmann,Frank Kannenberg,Wayne Weng,John R. Erbey,Ani John,Diane L. Tribble,(unknown),(unknown),Enrico P. Veltri	1
14	Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins 2001 ·The American Journal of Medicine ·Diane L. Tribble,Manfredi Rizzo,Alan Chait,(unknown),Patricia J. Blanche,Ronald M. Krauss	142
15	Antioxidants and atherosclerotic cardiovascular disease: unresolved issues 2001 ·Coronary Artery Disease ·Diane L. Tribble	3
16	Population Frequency Distributions of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B in Healthy Men and Women and Associations with Age, Gender, Hormonal Status, and Sex Hormone Use: The Stanford Five City Project 2000 ·Preventive Medicine ·Christopher D. Gardner,Diane L. Tribble,Deborah Rohm Young,David K. Ahn,Stephen P. Fortmann	33
17	Associations of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B with Lifestyle Factors in Healthy Women and Men: The Stanford Five City Project 2000 ·Preventive Medicine ·Christopher D. Gardner,Diane L. Tribble,Deborah Rohm Young,David K. Ahn,Stephen P. Fortmann	24
18	Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and β-Carotene 1999 ·Circulation ·Diane L. Tribble	226
19	The Role of Exercise in Weight Regulation in Nonathletes 1991 ·Sports Medicine ·Abby C. King,Diane L. Tribble	81
20	The pathophysiological significance of lipid peroxidation in oxidative cell injury 1987 ·Hepatology ·Diane L. Tribble,Tak Yee Aw,Dean P. Jones	258

About Diane L. Tribble

Diane L. Tribble is a scholar working on Biochemistry, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 65 papers that have together received 7.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (29 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Cancer, Lipids, and Metabolism (14 papers). The work is most often cited by research in Biochemistry (991 citations), Endocrinology, Diabetes and Metabolism (2.0k citations) and Nutrition and Dietetics (1.3k citations). Diane L. Tribble has collaborated with scholars based in United States, Netherlands and Norway. Frequent co-authors include Ronald M. Krauss, Alan Chait, Dean P. Jones, Ronald Brazg, Peter D. Wood, Robert H. Eckel, John W. Suttie, Rebecca M. Mullis, Stephen R. Daniels and Ira J. Goldberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact